Dashenlin Pharm Grp Co Ltd Strategic Asset Allocation Index
Dashenlin Pharm Grp Co Ltd strategic asset allocation index. Dashenlin Pharm Grp Co Ltd (603233) has a Strategic Asset Allocation Index of 81.8% as of June 2023. Strategic assets (PP&E of CN¥6.25 Billion plus long-term investments of CN¥-) total CN¥6.25 Billion, measured against net assets of CN¥7.64 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Dashenlin Pharm Grp Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Dashenlin Pharm Grp Co Ltd (2012–2022)
Strategic asset allocation index of Dashenlin Pharm Grp Co Ltd from 2012 to 2022. This chart shows how Dashenlin Pharm Grp Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 81.8%, representing strategic assets of CN¥6.25 Billion against net assets of CN¥7.64 Billion CNY. Check how tangible is Dashenlin Pharm Grp Co Ltd's equity to evaluate the tangible quality of the company's equity base.
Dashenlin Pharm Grp Co Ltd Strategic Asset Allocation Index by Year (2012–2022)
Dashenlin Pharm Grp Co Ltd strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Dashenlin Pharm Grp Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603233 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 88.8% | CN¥6.09 Billion | CN¥6.09 Billion | CN¥- | CN¥6.86 Billion | ▼ -6.5 pp |
| 2021 | 95.2% | CN¥5.65 Billion | CN¥5.65 Billion | CN¥- | CN¥5.94 Billion | ▲ +72.1 pp |
| 2020 | 23.1% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥5.57 Billion | ▼ -2.7 pp |
| 2019 | 25.8% | CN¥1.12 Billion | CN¥1.12 Billion | CN¥- | CN¥4.33 Billion | ▼ -6.0 pp |
| 2018 | 31.9% | CN¥983.18 Million | CN¥983.18 Million | CN¥- | CN¥3.09 Billion | ▲ +3.3 pp |
| 2017 | 28.6% | CN¥801.55 Million | CN¥801.55 Million | CN¥- | CN¥2.80 Billion | ▼ -18.0 pp |
| 2016 | 46.6% | CN¥625.16 Million | CN¥625.16 Million | CN¥- | CN¥1.34 Billion | ▼ -7.4 pp |
| 2015 | 54.0% | CN¥551.58 Million | CN¥551.58 Million | CN¥- | CN¥1.02 Billion | ▼ -22.8 pp |
| 2014 | 76.8% | CN¥441.66 Million | CN¥441.66 Million | CN¥- | CN¥574.85 Million | ▲ +16.6 pp |
| 2013 | 60.2% | CN¥355.04 Million | CN¥355.04 Million | CN¥- | CN¥589.93 Million | ▲ +41.7 pp |
| 2012 | 18.5% | CN¥70.56 Million | CN¥70.56 Million | CN¥- | CN¥381.11 Million | — |